Results 221 to 230 of about 7,440,138 (398)

Patents and pharmaceutical drugs : understanding the pressures on developing countries [PDF]

open access: yes
This paper offers a discussion to the question of why there are pressures on developing countries for introducing and/or reinforcing patent protection to pharmaceutical drugs. Patent protection is an important component of a complex strategy developed by
Nogues, Julio
core  

KCS1 and VIP1, the genes encoding yeast phosphoinositol pyrophosphate synthases, are required for Ca2+‐mediated response to dimethylsulfoxide (DMSO)

open access: yesFEBS Open Bio, EarlyView.
Ca2+‐mediated response to DMSO was investigated in Saccharomyces cerevisiae cells expressing Ca2+‐dependent aequorin. Cell exposure to DMSO induced a cytosolic Ca2+ wave dependent on the integrity of the Cch1/Mid1 channel. Deletion of KCS1 or VIP1 genes encoding the phosphoinositol pyrophosphate (PP‐IP) synthases suppressed the DMSO‐induced Ca2 ...
Larisa Ioana Gogianu   +4 more
wiley   +1 more source

Defense of book critical of drug industry [PDF]

open access: bronze, 2003
Daniel S. Streetman   +1 more
openalex   +1 more source

Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs [PDF]

open access: yes
The pharmaceutical industry is characterized as having substantial investment in R&D and a large number of new product introductions, which poses special problems for price measurement caused by the quality of drug products changing over time. This paper
Abe Dunn
core  

B2B Infrastructures in the Process of Drug Discovery and Healthcare

open access: yes
In this paper we describe a demonstration of an innovative B2B infrastructure which can be used to support collaborations in the pharmaceutical industry to achieve the drug discovery goal.
Boniface, M.J.   +2 more
core  

Home - About - Disclaimer - Privacy